Business Standard

Eris Lifesciences buys dermatology brands from Dr Reddy's for Rs 275 crore

In January Eris had bought some derma brands from Glenmark Pharma as well

Eris buys derma brands from Dr Reddy’s for Rs 275 cr
Premium

Sohini Das Mumbai
Dr Reddy’s Laboratories on Thursday said that it has signed a deal to divest certain non-core brands of the company in the dermatology segment to Eris Lifesciences for Rs 275 crore.

The divested portfolio saw sales of Rs 60 crore as of IQVIA moving annual turnover (MAT) data December 2022.

M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), DRL said: “India is a focus market for us. We aspire to break into the top 5 in India. Today’s announcement is in line with our stated intention of pursuing a strategy that involves growing brands organically combined with acquisitions

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in